COMMUNIQUÉS West-GlobeNewswire

-
The Ensign Group Adds Skilled Nursing Facility in California
02/06/2025 -
The Ensign Group Acquires Two Skilled Nursing Facilities in Idaho
02/06/2025 -
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
02/06/2025 -
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2025 -
Abivax Presents First Quarter 2025 Financial Results
02/06/2025 -
LifeLabs partners with POGO to support their ongoing mission of helping Ontario children with cancer
02/06/2025 -
Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
02/06/2025 -
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
02/06/2025 -
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial
02/06/2025 -
The Worsening Pandemic of Gambling Highlighted in the Journal of American Physicians and Surgeons
02/06/2025 -
‘Stealthy’ Endocrine Effects of the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
02/06/2025 -
Elite Clinical Network Appoints Christopher Brennan as Chief Executive Officer
02/06/2025 -
DentPrime Signs New Sponsorship Agreement with Czech Republic's Renowned Ice Hockey Team Orli Znojmo
02/06/2025 -
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02/06/2025 -
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules
02/06/2025 -
HOOPP appoints Reena Carter as new Chief Financial Officer
02/06/2025 -
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
02/06/2025 -
Civitas Networks for Health Opens Registration for 2025 Annual Conference
02/06/2025 -
Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled Therapies
02/06/2025
Pages